Thymalfasin
产品说明书
 |
同义名 : | 胸腺肽alpha1 ;Thymosin α1; Thymosin α1 (human, mouse, rat, bovine) |
| CAS号 : | 62304-98-7 | |
| 货号 : | A225779 | |
| 分子式 : | C129H215N33O55 | |
| 纯度 : | 98% | |
| 分子量 : | 3108.28 | |
| MDL号 : | MFCD00076889 | |
| 存储条件： |
Pure form Sealed in dry, store in freezer, under -20°C In solvent -20°C:3-6个月-80°C:12个月 |
|
| 溶解度 : | - |
| 生物活性 | |||
|---|---|---|---|
| 描述 | Thymalfasin (thymosin-alpha 1) is an immunomodulating agent able to enhance the Thl immune response. | ||
| 临床研究 | |||||
|---|---|---|---|---|---|
| NCT号 | 适应症或疾病 | 临床期 | 招募状态 | 预计完成时间 | 地点 |
| NCT00935558 | Breast Cancer | Phase 2 | Withdrawn(no patients enrolled... 展开 >>) 收起 << | - | Denmark ... 展开 >> Department of Oncology, Copenhagen University Hospital, Herlev Herlev, Denmark, 2730 收起 << |
| NCT03659578 | Non-small Cell Lung Cancer | Phase 2 | Recruiting | September 2020 | China, Guangdong ... 展开 >> Sun yat-sen University Cancer Center Recruiting Guangzhou, Guangdong, China, 510000 Contact: Bo Qiu, Attending +86-020-87343031 qiubo@sysucc.org.cn Contact: Hui Liu, Professor 收起 << |
| NCT00040027 | Hepatitis C H... 展开 >>epatitis C, Chronic 收起 << | Phase 3 | Completed | - | - |
| 实验方案 | |||
|---|---|---|---|
| 1mg | 5mg | 10mg | |
|
1 mM 5 mM 10 mM |
0.32mL 0.06mL 0.03mL |
1.61mL 0.32mL 0.16mL |
3.22mL 0.64mL 0.32mL |
| 参考文献 |
|---|